Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Texas Heart Institute designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Estimated Study Time
The estimated time to complete this activity, including review of the materials and completion of the course assessment is 45 minutes.
If you previously completed and received credit for the live CME-sponsored grand rounds entitled, Vagus Nerve Stimulation for the Treatment of Heart Failure: Exploring the Heart-Brain Corridor, on November 22, 2013, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.
Disclosure of Relationships Faculty Disclosure
It is the intent of the Texas Heart Institute to ensure that its educational mission and its continuing medical activities in particular, should not be influenced by the special interests of individuals associated with its program.
In accordance with the guidelines of the Accreditation Council for Continuing Medical Education, everyone in a position to control content (faculty, planners, reviewers, and others who control content including their spouse/partner) has disclosed to Texas Heart Institute their relevant financial relationships with commercial interests. The Institute defines “relevant financial relationships” as financial relationships of the individual (including those of the individual’s spouse or partner) in any amount occurring within the past 12 months that create a conflict of interest. The ACCME defines “commercial interest” as any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients.
Dr. Sabbah is a consultant for Boston Scientific Corporation. He is on the Scientific Advisory Board for BioControl Medical. Dr. Sabbah has received research grants from BioControl Medical and Boston Scientific.
The Planning Committee has nothing to disclose.
The THI CME Staff have nothing to disclose.
The Program Reviewers have nothing to disclose.